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Charcot-Marie-Tooth Disease Type 2A
Caused by Mutation
in a Microtubule Motor KIF1B
gaku et al., 1994; termed KIF1B hereafter) that we call
KIF1B. The two isoforms, splice variants of the same
gene mapped on mouse chromosome 4E, share the
N-terminal motor domain, but have distinct tail domains.
The tail domain of KIF1B more closely resembles that
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and Nobutaka Hirokawa1,4 of KIF1A, a motor that transports synaptic vesicle pre-
cursors (Okada et al., 1995). Because their tail domains1Department of Cell Biology and Anatomy
2 Department of Pediatrics share no homology with each other, the cargos of
KIF1B and KIF1B would be predicted to be differentGraduate School of Medicine
University of Tokyo (Nakagawa et al., 1997, 1998). Here, we present evi-
dence that KIF1B transports synaptic vesicle precur-Hongo, Tokyo 113-0033
Japan sors and we also characterize its functional significance
in vivo, showing that knockout mice developed neuro-3 Department of Neurology
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Charcot-Marie-Tooth disease (CMT), the most com-Niigata University
Niigata 951-8585 mon inherited peripheral neuropathy in humans with a
prevalence of 1/2500, is clinically characterized byJapan
weakness and atrophy of distal muscles, depressed or
absent deep tendon reflexes, and mild sensory loss (Shy
et al., 1999). It has been classified into types I (myelino-Summary
pathy) and II (axonopathy) by using motor nerve conduc-
tion velocity (MNCV) as a marker of myelin degenerationThe kinesin superfamily motor protein KIF1B has been
shown to transport mitochondria. Here, we describe (Harding and Thomas, 1980). CMT2A, an autosomal
dominant subtype of type II CMT, was mapped to humanan isoform of KIF1B, KIF1B, that is distinct from
KIF1B in its cargo binding domain. KIF1B knockout chromosome 1p35-36 (Ben Othmane et al., 1993), but
the gene has not yet been identified. Interestingly, themice die at birth from apnea due to nervous system
defects. Death of knockout neurons in culture can be human KIF1B locus is closely linked to the CMT2A inter-
val (Gong et al., 1996; Nakagawa et al., 1997). In addition,rescued by expression of the  isoform. The KIF1B
heterozygotes have a defect in transporting synaptic we report that the phenotype of kif1B/ mice resembles
the symptoms of the disease. Therefore, we analyzedvesicle precursors and suffer from progressive muscle
weakness similar to human neuropathies. Charcot- the KIF1B locus in CMT2A patients, and we discovered
a Q98L missense mutation in the ATP binding consensusMarie-Tooth disease type 2A was previously mapped
to an interval containing KIF1B. We show that CMT2A of motor domain. Our results showing that the Q98L
mutant KIF1B protein has decreased ATPase activitypatients contain a loss-of-function mutation in the mo-
tor domain of the KIF1B gene. This is clear indication and motility lead us to suggest that a haploinsufficiency
of this motor protein is responsible for CMT2A neuropa-that defects in axonal transport due to a mutated mo-
tor protein can underlie human peripheral neuropathy. thy, both in this mouse model and in humans.
Introduction Results
Axonal transport supplies essential organelles and ma- New Motor KIF1B Associates with Synaptic
terials to nerve endings mainly by using microtubules Vesicle Precursors
as tracks. The kinesin superfamily of molecular motor kif1B cDNA was cloned and sequenced from a mouse
proteins (KIFs) has over 40 members potentially func- brain library probed with a cDNA fragment of kif1B motor
tioning in various aspects of axonal transport (Hirokawa, domain (Nangaku et al., 1994). This longer isoform con-
1998). All superfamily members have similar motor do- sisted of 1770 amino acids, with a predicted molecular
mains, which may have evolved by multiple gene dupli- weight of 199 kDa (GenBank accession number AB023656;
cations. The remaining portions of the molecules are Nakagawa et al., 1997). Its N-terminal motor domain
greatly diverged, presumably allowing association with (1–660 aa) was 100% identical to that of KIF1B at the
multiple classes of cargo molecules. Indeed, the func- nucleotide level. Other domains of the two, however,
tional specificity of each motor is supported by a series shared no significant homology, suggesting that an al-
of knockout mice displaying distinct developmental and ternative splicing mechanism generated two different
subcellular phenotypes (Yonekawa et al., 1998; Tanaka motors from a single gene (Figure 1A).
et al., 1998; Nonaka et al., 1998; Takeda et al., 1999) We characterized the cargo organelles of KIF1B us-
that were only mildly compensated by other KIFs. ing a specific antibody against its tail domain, which
Here, we have identified and characterized an isoform detected a single band of the predicted size in brain
of the conventional mitochondrial motor KIF1B (Nan- and bands of other sizes (presumably splicing variants
or posttranslationally modified forms) in other tissues
(Figure 1B; Conforti et al., 1999; Gong et al., 1999). This4 Correspondence: hirokawa@m.u-tokyo.ac.jp
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Figure 1. Molecular Cloning and Antibody
Characterization of Mouse KIF1B
(A) Schematic representation of kif1B cDNAs.
The DNA matrix plot (window size 30, mini-
mal % score  65) shows splicing variation
in the tail domains.
(B) Immunoblot of adult mouse tissues probed
with the anti-KIF1B antibody.
(C and D) Immunofluorescence microscopy
against KIF1B. (C) Motor neurons in the an-
terior horn. (D) Cross-section of the spinal
cord showing axonal tracts. Bar, 10 m.
antibody did not cross-react with KIF1A because we did not expand, and thus apnea could well explain the
cause of newborn lethality (Figure 3E). This apnea prob-had chosen a KIF1B-specific sequence as an antigen.
As KIF1B was widely distributed both in cell bodies ably did not have a peripheral origin, because the histol-
ogy and ultrastructure of the lung and the intercostaland axons of neurons (Figures 1C and 1D; also see
supplemental Figure S1, available online at http://www. muscles involved in respiration did not reveal any signifi-
cant defects (see supplemental Figure S2).cell.com/cgi/content/full/105/5/587/DC1), and its tail
domain has a 61% amino acid identity to that of the Newborn kif1B/ pups displayed multiple neurologi-
cal abnormalities. They were insensitive to pinchingKIF1A motor for synaptic vesicle precursors (Okada et
al., 1995), we tested its association with various synaptic stimuli (Table 1), and their body posture was severely
lordotic with dropping forelimbs (Figure 3D), represent-proteins. In a density gradient centrifugation, KIF1B
cofractionated with membranous organelles containing ing an overall reduction of motosensory neural function.
kif1B/ brains were reduced 10% in size compareda synaptic vesicle protein, synaptotagmin (Figure 2A).
GST-pulldown and immunoprecipitation assays with a to the control. In sections, the cellularity, organization,
and development of the brain stem nuclei and commis-membrane vesicle fraction (P3) of mouse brain showed
that KIF1B was specifically associated with vesicles sural fibers were significantly affected (Figures 3F–3I;
also see supplemental Figure S3). The number of neu-containing synaptic vesicle proteins synaptotagmin,
synaptophysin, and SV2. However, no specific associa- ronal cell bodies was less than 25% of that in the control.
Neuronal loss in the kif1B/ respiratory center, or dorsaltion was detected with the synaptic plasma membrane
proteins SNAP-25 and syntaxin, the mitochondrial and ventral medullary reticular nuclei (MdD and MdV),
may be the primary cause of the newborn apnea. Themarker COX I, or the KIF17 associating protein mLin-10
(Figures 2B and 2C; Setou et al., 2000). These results cellularity and organization of the hippocampus was
also affected (Figures 3H and 3I). To examine the struc-were further confirmed by immunoelectronmicroscopy
(immuno EM) showing that KIF1B significantly coloca- ture of synapses, we chose the anterior horn areas of
the spinal cord and found significant reduction in thelized with synaptic vesicle proteins on vesicle mem-
branes (Figure 2D). density of synaptic vesicles of the nerve terminals (Fig-
ure 3J; also see supplemental Figure S2C).
Fatal Neuronal Defects in kif1B/ Mice
In order to assess the functional significance of KIF1B KIF1B Acts Cell Autonomously in Neurons
We then cultured kif1B/ or kif1B/ hippocampal neu-in vivo, we generated knockout mice by gene targeting.
We replaced a 2.2 kb portion containing the coding rons to assess the neuronal loss phenotype in vitro. The
neurons were observed for five successive days afterregion of the ATP binding consensus P loop of the motor
domain with a positive selection cassette (Figure 3). plating, classified with established criteria for neuronal
differentiation (Goslin and Banker, 1991), and quanti-kif1B/ pups were delivered in normal Mendelian ratios,
but died within 30 min of birth. Their pulmonary alveoli tated. As shown in Figures 4A and 4B, the viability of
Molecular Motor and Charcot-Marie-Tooth Disease
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Figure 2. Association of Mouse KIF1B with Synaptic Vesicle Precursors
(A) Nycodenz density-gradient flotation assay indicating that KIF1B was present in the vesicle fraction containing synaptotagmin. Arrows
indicate the floated peak.
(B) GST pull-down assay of KIF1B-associated vesicles. Synaptic vesicle proteins were specifically detected in the vesicles associated with
KIF1B tail region (aa 885–1770), but not with the truncated construct (PH; aa 885–1528) lacking the pleckstrin homology (PH) domain.
(C) Immunoprecipitation of the vesicle fraction of mouse brain using an anti-KIF1B and several anti-synaptic vesicle protein antibodies. KIF17
was used for control. Note that synaptic vesicle proteins synaptotagmin, synaptophysin, and SV2 were specifically detected in the vesicles
coimmunoprecipitated with KIF1B. COX I, cytochrome oxidase I, a marker for mitochondria.
(D) Immuno EM indicating the colocalization of KIF1B (10 nm gold) and synaptic vesicle proteins (5 nm gold) on axonal vesicles. Bar, 100
nm. The percentages of the number of vesicles carrying both signals over the number of all the vesicles in randomly chosen areas were
indicated. **, p  0.001 (chi-square for independence test).
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of several proteins in the peripheral nerves of kif1B/Table 1. Defective Growth and Hyporesponsivity of the Newborn Pups
and kif1B/ mice, in the steady state (Figure 5A) and
Genotype / / / in a cumulative manner by nerve ligation for 2 hr (Figure
(n  30) (n  67) (n  33)
5B). The level of KIF1B protein in the sciatic nerve ofBody weight (g) 1.23 	 0.06 1.21 	 0.04 0.97 	 0.03*
kif1B/ mice was half of that in kif1B/ mice, support-Crown-Ruamp 3.0 	 0.2 2.9 	 0.2 2.5 	 0.1**
Length (cm) ing the existence of haploinsuffiency (Figures 5A and
Pinching response 5B). In terms of synaptic vesicle proteins, the levels of
Neck Strong 30 66 0 synaptotagmin and SV2 were about 60% of wild type,
Weak 0 1 30 while the levels of synaptic membrane proteins SNAP-25
None 0 0 3
and syntaxin, mitochondrial protein COX I, or a controlTail Strong 24 59 0
kinesin KIF5A, did not significantly change in the hetero-Weak 6 8 29
None 0 0 4 zygotes (Figure 5A). The nerve ligation experiment fur-
ther indicated that the transport of synaptic vesicle pro-All data are given as mean 	 SD. *p  0.05, **p  0.001, t test.
teins was specifically decreased (Figure 5B). In this
experiment, the amount of synaptic vesicle proteins be-
ing accumulated at the proximal portion in heterozygote
kif1B/ neurons was significantly reduced after day 2.
axons was decreased compared to that in wild-type
By day 5, 10% and 90% of kif1B/ and kif1B/ neurons,
axons, while the amount of synaptic plasma membrane
respectively, had survived (Figure 4B). As the knockout
proteins being accumulated at the proximal portion was
neurons were cocultured with wild-type glia, we con-
not changed between the heterozygote and wild-type
clude that kif1B acts cell autonomously in neurons, in
axons. Staining for total protein also showed no obvious
contributing to cell viability. In order to assess which
difference in the levels of major cytoskeletal proteins
isoform of KIF1B was more responsible for the neuronal
(Figure 5D). Thus, the reduction in synaptic vesicle pro-
loss phenotype, we attempted a rescue experiment. Ad-
tein transport was unlikely to be due to a nonspecific
enoviral vectors encoding EGFP-tagged isoforms were
overall impairment of axonal transport. In the spinal
first used to infect fibroblasts to verify expression by
cord, where the neuronal cell bodies were located, only
immunoblotting (Figure 4E). Importantly, infection with
the level of KIF1B decreased, while levels of synapto-
KIF1B, but not KIF1B expressing virus, significantly
tagmin and SV2 did not (Figure 5C). Together these data
rescued the viability of kif1B/ neurons (Figures 4C and
suggested that the levels of synaptic vesicle proteins
4D). Any potential deficiency in mitochondrial transport
decreased in nerve axons but not in cell bodies of het-
caused by lack of KIF1Bwas apparently compensated
erozygotes, reflecting a specific impairment of axonal
for with redundant mitochondrial motors (such as con-
transport normally powered by the KIF1B motor.
ventional kinesins KIF5A, B, and C: Tanaka et al., 1998;
Kanai et al., 2000), because no change in mitochondrial
distribution was observed in the knockout in vitro (see kif1B/ Mice Suffered from a Chronic
Peripheral Neuropathysupplemental Figure S4) or in vivo (not shown). Thus,
KIF1B was probably the main isoform responsible for kif1B/ mice gradually acquired a staggering gait after
one year of age. They finally became unable to supportthe neuronal loss in kif1B/ mice.
their own weight, and could move only by occasional
hops (Figure 6A; also see supplemental video clip VC1).Specific Impairment of the Axonal Transport
in kif1B/ Mice We suspected a chronic neuropathy, and tested 2- and
12-month-old mice with the following behavioral andWe then assessed the protein content of the peripheral
nerves of heterozygotes, to test if specific transport of physiological examinations.
kif1B/ mice showed progressive muscle weaknesssynaptic vesicle precursors was impaired by haploinsuf-
ficiency of the motor protein. The sciatic nerves of and motor discoordination in behavioral tests. We per-
formed a fixed bar and rotarod test, and detected signifi-2-month-old kif1B/ mice were chosen for the study,
because they did not show apparent phenotypes that cantly shorter retention times for 12-month-old kif1B/
mice than for controls (Table 2; supplemental video clipscould develop secondary defects. We compared levels
Figure 3. Targeted Disruption of Mouse kif1B Gene
(A) The targeting strategy for kif1B knockout. Strategy for genomic Southern blotting by HincII is also indicated. AT/pau, AT-rich pausing
signal; pBS, pBluescriptII-SK(); and Hc, HincII.
(B) Genomic Southern blotting in which the recombinant allele gave an additional band of 2.1 kb.
(C) Immunoblot analysis of crude extracts from 18.5 dpc mouse brains with anti-KIF1B and anti-KIF1B antibodies, respectively. In both
cases, no bands were detected from kif1B/ samples.
(D) Appearance of a newborn litter. Note dropping forelimbs (arrows) and lordotic body posture (arrowheads) specifically found in kif1B/
pups.
(E) HE-stained lung sections. Note the pulmonary alveoli (asterisks) were only expanded with air in the control mice. Bar, 25 m.
(F–I) Brain defects in kif1B/ mice. (F and G) Comparison of respiratory centers in the cross sections of medulla oblongata of kif1B/ (F) and
kif1B/ (G) mice on 18.5 dpc. MdD, dorsal medullary reticular nucleus; MdV, ventral medullary reticular nucleus, VLRt, ventrolateral reticular
nucleus. Bar, 500 m. (H and I) Frontal sections of cerebral hemispheres of kif1B/ (H) and kif1B/ (I) embryos on 18.5 dpc, with defective
formation of commissural fibers. Arrowheads, anterior commisure; arrows, internal capsule. Bar, 600 m.
(J) Reduced density of synaptic vesicles in the nerve terminals at the anterior horn region of the spinal cord of kif1B/ mice on 18.5 dpc.
#1–#4 represent four different regions counted.
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Figure 4. Neuronal Cell Death in Primary Cul-
ture of kif1B/ Hippocampus
(A) Time course of the primary culture of each
genotype. Note severe neuronal death of the
kif1B/ neurons with a significant delay in
differentiation. Arrows, dead cells. Bar, 20 m.
(B) Survival and differentiation curves of
plated neurons of each genotype. Relative
index of the neuronal cell number was calcu-
lated taking the initial cell number per unit
area as 100%.
(C–E) Rescue experiments. (C) Rescued cul-
ture of kif1B/ hippocampal neurons on the
fifth day of infection. Green fluorescence indi-
cates the neurons expressing respective ade-
noviral vectors expressing the kif1B isoforms
tagged by EGFP. Note that the neurons
reached highly differentiated stages only with
the kif1B construct. Arrows, dead cells. Bar,
10 m. (D) Quantification of the rescue effi-
ciency of kif1B/ neurons. “*”, p  0.001. ,
kif1B; , kif1B; N, noninfected control. (E)
Immunoblot of infected fibroblast lysates us-
ing an anti-GFP antibody. Each EGFP-tagged
protein gave a band of the expected molecu-
lar weight.
VC2 and VC3). In the fixed bar test, the tendency to fall (Figure 6C). The amplitudes were significantly reduced
in kif1B/ mice but the conduction velocity did not showwas significantly higher in 12-month-old kif1B/ mice,
which were tremulous, than in controls (Table 2). In the any significant difference (Figures 6C–6D; Table 2), sug-
gesting that demyelination of the nerves was not a fac-rotarod test, the heterozygous mice also showed sig-
nificantly impaired performance (Figure 6B; Table 2) tor. In addition, histological analyses of the distal mus-
cles did not show significant changes (data not shown).through five consecutive days training. The grasping
power of 12-month-old kif1B/ mice was 20%–25% Thus, it is likely that defects in neuronal axons contrib-
uted most significantly to the peripheral neuropathy ofweaker than that of kif1B/mice (Table 2), while sensory
impairment, examined with a hot-plate test, was not kif1B/ mice.
significant (data not shown).
To assess the nature of the muscle weakness, we Human Kif1B Mutation Causes
CMT2A Neuropathyanalyzed the evoked compound action potentials of 12-
month-old sciatic nerves recorded at the plantar mus- Finally, we showed that CMT2A is a KIF1B-based neu-
ropathy in humans. We suspected this because of thecles following direct stimulation at the midthigh level
Molecular Motor and Charcot-Marie-Tooth Disease
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Figure 5. Decreased Levels of the Synaptic
Vesicle Proteins in kif1B/Sciatic Nerve Axons
(A) Immunoblotting of the sciatic nerve ex-
tracts. Ten micrograms of protein was loaded
in each lane. The protein levels in kif1B/
nerves are indicated as a percentage of those
in kif1B/ nerves.
(B) Immunoblotting of pooled organelles in
sciatic nerves 2 hr after the ligation. The pro-
tein levels from 1 cm regions proximal (Prox)
and distal (Dist) to the ligated sites were com-
pared.
(C) Immunoblotting of the spinal cord extracts
prepared as in (A).
(D) Protein staining by Coomassie brilliant
blue of the extracts from sciatic nerves and
spinal cords. Ten micrograms of total protein
was loaded in each lane.
similarity of the mouse phenotype to the human disease rates of the wild-type and Q98L recombinant KIF1B
full-length proteins, which were 3.6 	 0.5 and 0.0 	 0.4and because KIF1B is linked to the mapped CMT2A
interval on chromosome 1. We analyzed a previously nmol/mg/min, respectively. Thus, the ATPase activity of
the mutated motor was significantly reduced. We furtherwell characterized human pedigree of CMT2A, with an
autosomal dominant hereditary pattern (Figure 7A; Saito expressed Q98L or wild-type KIF1B in Vero cells to
test their motility in vivo. Due to its motility toward theet al., 1997). Based upon a complete exon-intron struc-
ture of human KIF1B gene (H.W.Y., unpublished data), plus ends of the microtubules, overexpressed wild-type
KIF1Bprotein accumulated at the cell periphery (Figureeach of the 47 exons was amplified by genomic PCR
and subjected to SSCP and/or direct sequence analysis. 7D, left). In contrast, the Q98L mutant protein remained
and aggregated in the perinuclear region (Figure 7D,Among many single nucleotide polymorphisms (SNPs),
we detected that an abnormal SSCP mobility shift in right). These data suggested that the Q98L point muta-
tion resulted in a functional loss of motor activity.exon 3 completely correlated with the clinical manifesta-
tion. It was detected in all four affected people in this
pedigree, but not in eight unaffected siblings or 95 Discussion
healthy unrelated Japanese controls (Figure 7B). Then
we directly sequenced the PCR product and revealed In this study, we have identified a motor protein KIF1B
that transports synaptic vesicle precursors. In addition,a heterozygous A→T point mutation, which transformed
Q98 to L in the affected individuals (Figure 7C). we generated kif1B heterozygous mice that mimic hu-
man CMT2A neuropathy. The evidence we present hereThis Q98L mutation occurred in the middle of the P
loop, the consensus ATP binding site, and would thus indicates that the autosomal dominant hereditary pat-
tern of CMT2A could be explained by haploinsufficiencybe predicted to disrupt the function of this mechano-
chemical enzyme. Thus, we tested the motor activity of of KIF1B: (1) kif1B/ mice reduced the KIF1B level
to half, and caused a late-onset axonopathy similar torecombinant mouse KIF1B, with the Q98L mutation.
First, we measured microtubule-activated ATP turnover CMT2A. (2) Human KIF1B is closely linked to CMT2A.
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Figure 6. Chronic Peripheral Neuropathy in kif1B/ Mice
(A) Typical posture of 1.5-year-old mice. Note that the kif1B/ mouse could not support its own body weight.
(B) Retention time in the rota-rod test of 2- and 12-month-old mice in a trial of five successive. In spite of improvement after five days’ training,
the retention time of 12-month-old kif1B/ mice was still significantly shorter than that of kif1B/ mice (n  12, p  0.005, ANOVA test).
(C and D) Electrophysiological analysis of the sciatic nerves of 12-month-old mice. (C) Typical traces of the evoked action potentials at the
planter muscles. (D) Quantification of the motor nerve conduction velocities (MNCV) and the amplitudes of evoked muscle potentials. Although
the amplitude was reduced, the MNCV did not significantly change, suggesting an axonal origin of the disease.
(3) The human Q98L mutation completely correlated with proteins such as synaptotagmin and SV2, were specifi-
cally decreased in the peripheral axons of kif1B/ mice.the clinical manifestation. (4) The Q98L mutation dis-
rupted the motor function of KIF1B. (5) As a functional The functional significance of KIF1B was even more
apparent in kif1B/ newborn mice that died from apnea.consequence, the levels of the cargo, synaptic vesicle
Table 2. Animal Behavioral Analysis
2 months of age 12 months of age
Age and genotype / / / /
Fixed bar test (sec) (n  11) 46.0 	 3.0 40.0 	 6.0 50.0 	 3.0 16.0 	 3.0*
Grip strength of forelimbs (kgw) 0.072 	 0.002 0.075 	 0.002 0.088 	 0.003 0.071 	 0.018**
Grip strength of hindlimbs (kgw) 0.037 	 0.002 0.038 	 0.002 0.049 	 0.002 0.037 	 0.002**
(n  11)
Motor nerve conduction velocity 34.7 	 5.6 34.7 	 6.2
(MNCV) (m/s) (n  15)
Amplitude of muscle potential 3.07 	 2.32 1.89 	 1.19***
(mV) (n  15)
Data are given as mean 	 SE in fixed bar and grip strength experiments and mean 	 SD in electro physiological experiment. *p  0.01,
(Mann-Whitney’s u test). **p  0.0005, (t test). ***p  0.05, (Mann-Whitney’s u test).
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Figure 7. A Loss-of-Function Mutation in Human KIF1B Gene from CMT2A Patients
(A) Pedigree of family #694. Circles, females; squares, males; cross-hatched, deceased individuals; open figures, unaffected; closed figures,
affected.
(B) Mobility shifts in the PCR-SSCP analyses for the P loop exon 3. Arrows, shifted bands specifically observed in the affected individuals.
(C) Sequence electropherogram in the P loop region. In the sample from affected individual, A and T simultaneously read in the mutated
codon, resulting in a heterozygous Q98L point mutation.
(D) Immunofluorescence of Vero cells transfected with either wild-type or Q98L mutant KIF1B constructs. Red and green signals indicate
for KIF1B and tubulin, respectively. Note the difference in the accumulated positions of KIF1B protein (arrows). Bar, 15 m.
Impaired development of brain stem nuclei and commis- showing a reduction of the density of synaptic vesicles
in the nerve terminal. However, the phenotypes of thesural axons, and impaired synaptic formation in the spi-
nal cord could be considered more severe phenotypes kif1B/ mice were more severe than those of kif1A/
mice that could survive for about 24 hr after birth. Theof the peripheral neuropathy seen in kif1B/mice. The
low survival rate of kif1B/ neurons, which was rescued neurological findings such as dropping forelimbs, lor-
dotic posture, and apnea were also specific to kif1B/by expressing KIF1B cDNA, but not by KIF1B, sug-
gested that KIF1B acts cell autonomously in neurons, newborn mice. This difference of severity could be ex-
plained by the fact that KIF1B was expressed in earlywhich is consistent with the clinical definition of CMT2A
as an axonopathy, rather than a myelinopathy. stages of development (supplemental Figure S1), while
KIF1A was expressed in later stages of neuronal devel-The transport of synaptic vesicle precursors was also
impaired in the mice lacking the related motor, KIF1A opment (Yonekawa et al., 1998). Although the patterns
of expression of KIF1B and KIF1A during development(Yonekawa et al., 1998). kif1A/ mice also exhibited
neurological phenotypes lethal in the newborn period, were different, they seemed to be functionally redundant
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sections, and quantified for four pairs of littermates as describedin some neurons for the transport of synaptic vesicle
previously (Yonekawa et al., 1998).precursors. KIF1A is neuron-specific but KIF1B has a
broader spectrum of tissue distribution, so that KIF1B
Rescue Experiment of Primary Culturescould also play some roles in transporting other vesicles
of Hippocampal Neurons
in nonneuronal tissues. The assessment of the genetic The culture procedure and quantitative observation were performed
interaction between these two related genes will be the as described previously (Goslin and Banker, 1991; Yonekawa et al.,
subject of future research. 1998). The neurons were classified into differentiation stages 0–4,
according to established criteria by Goslin and Banker (1991). ForHow could a molecular motor deficiency result in the
preparation of adenoviral constructs, the full-length cDNA of KIF1Bdescribed neurological symptoms? As axons lack pro-
and was tagged with EGFP (Clontech) at the C termini, and ligatedtein synthesis machinery, proteins essential for neuronal
into pAdex-Wt1 vector with a CAG promotor to produce the recom-
survival must be transported down the axons by molecu- binant adenovirus, as described previously (Nakata et al., 1998).
lar motors. Thus, reduced levels of a motor protein may 1.0 
 105 neurons were plated per 35 mmφ dish, infected by the
not sustain the requirements of axons. The deficiency same titer of KIF1B or KIF1B adenovirus on the day of plating,
and the survival rate observed after 5 days. The infection efficiencyin transport of synaptic vesicle precursors or other un-
was over 90%, and 50%–80% of infected kif1B/ neurons hadidentified cargo molecules such as neurotrophic factor
survived by day 5.receptors due to inactivation of KIF1B probably caused
impairment in nerve endings, revealed by the electron
Quantitation of Protein Levels in Sciatic Nervesmicroscopic and electrophysiological analyses and by
Two hours after ligation of the sciatic nerves, 1-cm-long portions
decreased neuronal survival in the knockout mice. The proximal or distal to the ligated sites were collected, immediately
conventional distal-first theory of axonal neuropathies, frozen in liquid nitrogen, crushed in mortars with RIPA buffer supple-
stating that distal muscles suffer earlier and more se- mented with protease inhibitors, and processed for immunoblotting
with AP-conjugated secondary antibody by the standard methodverely than the proximal muscles, can be partially ex-
(Hirokawa et al., 1990; Takeda et al., 2000).plained by the idea that longer axons need higher levels
of motor molecules. Accordingly, we propose here a
Behavioral Analysesnew disease entity of “motor proteinopathy,” represent-
For the fixed bar test, the mice were put on a horizontal woodening the paradigm for motor-protein-derived pathogene-
bar 20 mm in width. After being trained three times, the retention
sis of axonal neuropathies. time of the mice was recorded for a maximum of 60 s as described
previously (Kadotani et al., 1996). For the rota-rod test, the mice
were placed on a rotating rod accelerating from 4 to 40 rpm in 5Experimental Procedures
min, and the retention time was measured essentially as described
previously (Jones and Roberts, 1968). Three trials were given perMolecular Cloning and Biochemical Identification
day for five consecutive days. For the hot-plate test, mice wereof the Cargos
placed on a heat block of 56C and the latencies to forelimb andMouse kif1B cDNA was obtained from a 4-week-old ICR mouse
hindlimb licking were recorded with a cut-off latency of 60 s. Gripbrain cDNA library probed with a cDNA fragment of the kif1B motor
strength was measured as described previously (Meyer et al., 1979).domain. A rabbit polyclonal antibody specific to the KIF1B tail
domain was raised against a synthetic peptide TTTFESAITPSESS
GYDSADVESLVDREKELAC corresponding to the 1505–1536 aa, Motor Nerve Conduction Velocity (MNCV)
which was not homologous to the KIF1A tail. Molecular cloning, Peripheral nerve conduction velocity was determined for the sciatic
immunoblotting, immunohistochemistry, subcellular fractionation, nerve as described previously (Robertson et al., 1993) with slight
GST-pulldown, and vesicle immunoprecipitation were performed modifications. All of the recordings were performed being ignorant
essentially as described previously (Setou et al., 2000). Immuno EM of the genotypes. Under ether anesthesia, the sciatic nerve was
of the vesicles from rat cauda equina was performed according to viewed and directly stimulated at the level of the sciatic notch or
the method described previously (Takeda et al., 2000). Anti-synapto- midthigh with a 0.1 msec square wave, and the compound muscle
tagmin monoclonal antibody 1D12C5 was kindly provided by Dr. action potential was recorded in the plantar muscle of the hindlimb
Masami Takahashi. Anti-synaptophysin and anti-SV2 monoclonal with an electrode placed percutaneously. MNCV was calculated by
antibodies were kindly provided by Drs. A. Davies and I. Jones. Anti- dividing the conduction time by the distance between the stimulat-
SNAP-25 and anti-Mint1 (mLin-10); anti-syntaxin; anti-COX I; anti- ing and recording electrodes.
GFP antibodies were respectively purchased from BD Transduction
Laboratories; Sigma; Molecular Probes; and Clontech.
Genetic Analyses of CMT2A Patients
High-molecular-weight DNA was prepared from peripheral blood
Mouse Knockout leukocytes from 12 Japanese individuals in CMT2A family #694
Mouse kif1B genomic clones were obtained from a EMBL3 geno- (Saito et al., 1997). PCR amplification of 47 exons of KIF1B was
mic library of ES cell line J1 (Tanaka et al., 1998). A 2.2 kb region performed according to the primer sets as will be described else-
spanning the P loop exon and a part of the upstream exon (P-1) was where (H.W.Y., unpublished data). Exon 3 of human kif1B ortholog
replaced by a poly(A)-less neo selection cassette, and the knockout was amplified using the following primer set: 5-TGGAAGCAAT
procedures were performed as described previously (Harada et al., CAAGTAAGTATAGA-3 and 5-CCCCGCATAATGTTCAAGCC-3 un-
1994). The chimeric mice were back-crossed with C57BL/6J females der a condition of 30 s at 95C, 30 s at 60C, and 30 s at 72C for
in a specific pathogen free environment, and two independent lines 35 cycles, followed by a 10 min extension at 72C. The SSCP analysis
were used simultaneously. Wild-type kif1B alleles were detected by was performed using low pH buffer system to separate the longer
PCR amplification using the following primer set: 5-CGCTAGGG fragments (Kukita et al., 1997). PCR products were purified and
TTAAAGCACACGCTAC-3 and 5-TGAACTTAGAAATCCACCTGC sequenced directly with ABI sequencers (Perkin Elmer).
CTC-3. neo transgene was amplified as described previously (Ta-
naka et al., 1998). Functional Assay of Mutated KIF1B Protein
ATPase activity was determined using a standard method as de-
scribed previously (Maeda et al., 1992). Q98L mutation was intro-Quantitation of Synaptic Vesicle Density
Anterior horn of the spinal cord at the C4 level was processed for duced into a full-length mouse kif1B cDNA with PCR amplification
and confirmed by sequencing. Vero cells were transfected with cat-conventional electron microscopy. Sixty areas of synapses were
randomly chosen from the electronmicrographs of 100 nm-thick ionic lipids, cultured for 24 hr, and immunostained with the anti-
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KIF1B polyclonal antibody and an anti--tubulin monoclonal anti- Maeda, K., Nakata, T., Noda, Y., Sato-Yoshitake, R., and Hirokawa,
N. (1992). Interaction of dynamin with microtubules: its structurebody DM1A (Sigma).
and GTPase activity investigated by using highly purified dynamin.
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